Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 2 · 100%Moderate 0 · 0%High 0 · 0%

Angiotensin receptor blockers (ARB) alone vs angiotensin‐converting‐enzyme inhibitors plus ARB

Cardiovascular mortality · people with diabetes and kidney disease

Angiotensin receptor blockers (ARB) alone showed no clear difference in cardiovascular death Median compared with angiotensin‐converting‐enzyme inhibitors plus ARB (low certainty).

1 finding from 1 review

Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes only
RR 3.03 [0.62, 14.93]
4 studies · 992 participants
Low

Angiotensin receptor blockers (ARBs) vs another ARB

Cardiovascular mortality · people with diabetes and kidney disease

Angiotensin receptor blocker (ARB) showed no clear difference in cardiovascular death Median compared with another ARB (low certainty).

1 finding from 1 review

Angiotensin‐converting‐enzyme inhibitors and angiotensin receptor blockers for preventing the progression of diabetic… 2024 · Cochrane Headline outcomes only
RR 1.34 [0.47, 3.82]
4 studies · 1360 participants
Low